全国性组织性癌症筛查项目对胃癌死亡率的影响:一项合成控制研究
该研究采用合成控制法准实验分析,评估韩国和日本全国性组织性胃癌筛查项目对≥40岁人群年龄标准化胃癌死亡率及其他上消化道疾病死亡率的人群影响。韩国干预后平均率比为0.83(95%CI 0.71-0.96),日本为0.97(95%CI 0.88-1.07)。结论认为韩国筛查有明显获益,日本项目效果不确定。
要点
- 韩国全国性胃癌筛查与胃癌死亡率降低相关,平均率比0.83(95%CI 0.71-0.96)。
- 韩国其他上消化道疾病死亡率平均率比0.72(95%CI 0.57-0.90)。
- 日本胃癌死亡率平均率比0.97(95%CI 0.88-1.07),效果不确定。
核心结论
- 韩国全国性胃癌筛查有明显获益,而日本项目的有效性不确定。
- 韩国和日本的经验可为其他国家提供参考。
研究设计与样本
- 采用灵活合成控制法的准实验分析,评估全国性组织性胃癌筛查项目对≥40岁人群年龄标准化胃癌死亡率及其他上消化道疾病死亡率的影响。
- 使用世界卫生组织死亡率数据及世界银行和全球疾病负担研究的国家层面协变量进行分析。
- 比较干预后结局趋势与合成对照的反事实趋势,估计平均干预后率比及95%置信区间,并进行一系列敏感性分析。
主要发现
- 韩国胃癌死亡率平均干预后率比为0.83(95%CI 0.71-0.96),其他上消化道疾病死亡率平均率比为0.72(95%CI 0.57-0.90)。
- 韩国全国性筛查启动后第15年,率比达到0.59。
- 日本胃癌死亡率平均率比为0.97(95%CI 0.88-1.07),其他上消化道疾病死亡率平均率比为0.93(95%CI 0.68-1.28)。
- 敏感性分析显示日本的结果可能存在偏倚。
关键数值与推荐
- 韩国胃癌死亡率平均干预后率比0.83(95%CI 0.71-0.96)。
- 韩国其他上消化道疾病死亡率平均干预后率比0.72(95%CI 0.57-0.90)。
- 韩国全国性筛查启动后第15年率比达0.59。
- 日本胃癌死亡率平均干预后率比0.97(95%CI 0.88-1.07)。
- 日本其他上消化道疾病死亡率平均干预后率比0.93(95%CI 0.68-1.28)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 日本其他上消化道疾病死亡率分析的干预前拟合较差。
- 敏感性分析显示日本的结果可能存在偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Nationwide organized gastric cancer (GC) screening programs have been running for decades in South Korea and Japan. This study conducted a quasi-experimental analysis to assess the population impact of these programs on GC mortality. METHODS: We used the flexible synthetic control method (SCM) to estimate the effect of the screening programs on age-standardized GC mortality and other upper gastrointestinal (UGI) diseases (esophageal cancer and peptic ulcer) among people aged ≥40 years. World Health Organization mortality data and country-level covariates from the World Bank and the Global Burden of Diseases study were used for the analyses. We compared postintervention trends in outcome with the counterfactual trend of the synthetic control and estimated average postintervention rate ratios (RRs) with associated 95% confidence intervals (CIs). A series of sensitivity analyses were conducted. RESULTS: The preintervention fits were acceptable for the analyses of South Korea and Japan's GC mortality but poor for Japan's other UGI disease mortality. The average postintervention RRs were 0.83 (95% CI, 0.71-0.96) for GC mortality and 0.72 (95% CI, 0.57-0.90) for other UGI disease mortality in South Korea. The RR reached 0.59 by the 15th year after the initiation of nationwide screening. For Japan, the average RRs were 0.97 (95% CI, 0.88-1.07) for GC mortality and 0.93 (95% CI, 0.68-1.28) for other UGI disease mortality. Sensitivity analysis reveals the result for Japan may potentially be biased. CONCLUSIONS: South Korea's nationwide GC screening has apparent benefits, whereas the Japanese program's effectiveness is uncertain. The experiences of South Korea and Japan could serve as a reference for other countries.
引用
- Sun D, Mülder DT, Li Y, et al. The Effect of Nationwide Organized Cancer Screening Programs on Gastric Cancer Mortality: A Synthetic Control Study. Gastroenterology. 2023. PMID: 38007053. doi:10.1053/j.gastro.2023.11.286
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。